1. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
- Author
-
Holán V, Vítová A, Krulová M, Zajícová A, Neuwirth A, Filipec M, and Forrester JV
- Subjects
- Animals, Antibodies, Monoclonal administration & dosage, Antibodies, Monoclonal therapeutic use, Antigens, Heterophile immunology, CD4 Antigens immunology, Female, Graft Rejection immunology, Graft Survival, Immune Sera immunology, Immunization, Passive, Isoantigens immunology, Male, Mice, Mice, Inbred BALB C, Rats, Rats, Inbred Lew, Time Factors, Transplantation, Heterologous, Transplantation, Homologous, Corneal Transplantation immunology, Graft Rejection prevention & control, Immune Sera administration & dosage
- Abstract
The effects of passive transfer of antisera containing cytotoxic antibodies to allo- and xenoantigens on survival of corneal allografts and xenografts were evaluated in experimental models. Corneas from allogeneic B10 or xenogeneic rat Lewis donors were grafted orthotopically into BALB/c mice. Recipient mice were treated with donor-specific antisera administered at the period of grafting or at 2 weeks after transplantation. Rejection was determined by the severity of corneal opacity using a standard scoring system. Treatment of graft recipients with donor-specific antisera accelerated the onset of graft rejection and significantly shortened survival times of both corneal allografts and xenografts. Corneal xenografts, which had been accepted after treatment with anti-CD4 monoclonal antibody, were acutely rejected by the passive transfer of antiserum against xenoantigens. The results suggest that corneal grafts are vulnerable to antibody-dependent immunity and that cytotoxic antibodies against graft donor antigens can mediate rejection of both corneal allografts and xenografts.
- Published
- 2005
- Full Text
- View/download PDF